A multi-purpose biopharmaceutical manufacturing facility using a matrix of multi-functional cleanrooms can be adapted to efficiently meet the capacity challenges of both supplying clinical trials and launching products.
Mark Witcher
Advertisement
Mark Witcher is senior consultant at Brevitas Consulting, witchermf@aol.com
Articles by Mark Witcher
A matrix of multi-functional cleanrooms can be adapted for launching products.
Advertisement
Latest Updated Articles
Multi-Purpose Biopharmaceutical Manufacturing Facilities Part 1: Product Pipeline ManufacturingPublished: November 29th 2018 | Updated:
Multi-Purpose Biopharmaceutical Manufacturing Facilities Part II: Large-Scale ProductionPublished: November 29th 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
2
Establishing Risk Assessments for AI in Bio-Manufacturing
3
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
4
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
5
